These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 20061622)

  • 1. Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence.
    Albani D; Polito L; Forloni G
    J Alzheimers Dis; 2010; 19(1):11-26. PubMed ID: 20061622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective properties of resveratrol in different neurodegenerative disorders.
    Albani D; Polito L; Signorini A; Forloni G
    Biofactors; 2010; 36(5):370-6. PubMed ID: 20848560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal protection by sirtuins in Alzheimer's disease.
    Anekonda TS; Reddy PH
    J Neurochem; 2006 Jan; 96(2):305-13. PubMed ID: 16219030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of sirtuin-activating compounds in Alzheimer's disease.
    Gan L
    Drug News Perspect; 2007 May; 20(4):233-9. PubMed ID: 17637936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirtuins in cognitive ageing and Alzheimer's disease.
    Braidy N; Jayasena T; Poljak A; Sachdev PS
    Curr Opin Psychiatry; 2012 May; 25(3):226-30. PubMed ID: 22327552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.
    Aljada A; Dong L; Mousa SA
    Curr Opin Investig Drugs; 2010 Oct; 11(10):1158-68. PubMed ID: 20872319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT1 and neuronal diseases.
    Tang BL; Chua CE
    Mol Aspects Med; 2008 Jun; 29(3):187-200. PubMed ID: 17397914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.
    Huber K; Superti-Furga G
    Bioorg Med Chem; 2011 Jun; 19(12):3616-24. PubMed ID: 21306906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRTUIN 1: regulating the regulator.
    Zschoernig B; Mahlknecht U
    Biochem Biophys Res Commun; 2008 Nov; 376(2):251-5. PubMed ID: 18774777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirtuins in aging and age-related disease.
    Longo VD; Kennedy BK
    Cell; 2006 Jul; 126(2):257-68. PubMed ID: 16873059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic modification is linked to Alzheimer's disease: is it a maker or a marker?
    Lee J; Ryu H
    BMB Rep; 2010 Oct; 43(10):649-55. PubMed ID: 21034526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirtuins: a family of proteins with implications for human performance and exercise physiology.
    Lappalainen Z
    Res Sports Med; 2011 Jan; 19(1):53-65. PubMed ID: 21253976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins.
    Law IK; Liu L; Xu A; Lam KS; Vanhoutte PM; Che CM; Leung PT; Wang Y
    Proteomics; 2009 May; 9(9):2444-56. PubMed ID: 19343720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seven sirtuins for seven deadly diseases of aging.
    Morris BJ
    Free Radic Biol Med; 2013 Mar; 56():133-71. PubMed ID: 23104101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine sirtuins: initial characterization and expression of sirtuins 1 and 3 in liver, muscle, and adipose tissue.
    Ghinis-Hozumi Y; González-Gallardo A; González-Dávalos L; Antaramian A; Villarroya F; Shimada A; Varela-Echavarría A; Mora O
    J Anim Sci; 2011 Aug; 89(8):2529-36. PubMed ID: 21421831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol--a boon for treating Alzheimer's disease?
    Anekonda TS
    Brain Res Rev; 2006 Sep; 52(2):316-26. PubMed ID: 16766037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurobiology of sirtuins and their role in neurodegeneration.
    Donmez G
    Trends Pharmacol Sci; 2012 Sep; 33(9):494-501. PubMed ID: 22749331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuins--novel therapeutic targets to treat age-associated diseases.
    Lavu S; Boss O; Elliott PJ; Lambert PD
    Nat Rev Drug Discov; 2008 Oct; 7(10):841-53. PubMed ID: 18827827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirtuin 1 overexpression mice show a reference memory deficit, but not neuroprotection.
    Kakefuda K; Fujita Y; Oyagi A; Hyakkoku K; Kojima T; Umemura K; Tsuruma K; Shimazawa M; Ito M; Nozawa Y; Hara H
    Biochem Biophys Res Commun; 2009 Oct; 387(4):784-8. PubMed ID: 19643082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.
    Kirkitadze MD; Bitan G; Teplow DB
    J Neurosci Res; 2002 Sep; 69(5):567-77. PubMed ID: 12210822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.